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Blumea balsamfera (L.) DC. (B. balsamfera) extract has been shown to exhibit many biological 
activities. However, the anti-kinase, anti-phosphatase and cytotoxic activities of B. balsamfera 
are not well understood. Therefore, this study aimed to investigate the anti-kinase and 
antiphosphatase activities using MKK1, MSG5 and PP1 screening systems. Cytotoxic activity 
was evaluated using acute promyelocytic leukemia cell lines (HL-60). Methanol extracts of B. 
balsamfera were partitioned into hexane (HE), chloroform (CE), chloroform-methanol (CME), 
butanol (BE) and aqueous fractions (AQE). Only the CE fraction demonstrated toxic activity 
against PP1 screening system. Other fractions did not show activity in PP1 screening. CE 
fractions were further fractionated using silica gel chromatography and a further 11 fractions 
were obtained. Fraction 2 (CE.F2) showed activity against PP1 and was further fractionated 
and tested. CE.F2.F6.F3 fraction tested positive against PP1. Inhibition of PP1 by the F2.F6.F3 
fraction was further confirmed using an enzymatic reaction and the Vmax and Km constants 
were 124.999 µmol/ml.min and 204.624 µM, respectively. A Lineweaver-Burk plot outcome of 
F2.F6.F3 revealed decreasing of Km and Vmax values which supported the inhibition of PP1 
activities. Cytotoxic activities against HL-60 were observed for the CE, CE.F1, CE.F2 and CE.F7 
fractions. We have demonstrated that B. balsamfera and its specific fractions exhibited anti-
kinase and anti-phosphatase activities. These substances have the potential to be used as 
treatment agent for acute promyelocytic leukemia.  
 
